CSIMarket Company Name, Ticker, Customers, else..
 
Abcellera Biologics Inc   (ABCL)
Other Ticker:  
 
 

Abcellera Biologics Inc Balance Sheet Annual

ABCL


Select the Financial Report:   Period:   Fiscal Year:




New: More ABCL's historic Annual Balance Sheets >>

ABCL Balance Sheets
(Annual, GAAP in millions $)

 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021

ASSETS
Cash & cash equivalent 133.32 386.54 476.14 - -
Cash, Cash Eqvivalents Other - - - - -
Available-for-sale Securities, Debt Securities MA 627.27 499.95 246.84 - -
Cash & Short-term Investments 760.59 886.49 722.98 - -
Accounts receivable - - - - -
Unbilled Receivables, Current RE - - - - -
Notes Receivable, Current - - - - -
Cash Cash Equivalents And Marketable Securities 760.59 886.49 722.98 - -
Accounts And Accrued Receivable Current 30.59 38.59 160.58 - -
Inventories - - - - -
Other Current Assets 111.40 139.01 206.82 - -
Total Current Assets 871.99 1,025.49 929.80 - -
Equipment/Property/Plant Net - 217.26 111.62 - -
Goodwill net 47.81 47.81 47.81 - -
Intangible Assets 120.43 131.50 148.39 - -
Long-term investments 65.94 72.52 50.31 - -
Accounts Receivable, Net, Noncurrent - - - - -
Financial Instruments - - - - -
Tax Assets, Noncurrent - - - - -
Other Assets, Noncurrent 385.00 48.00 30.64 - -
Deferred, Prepaid and Other Assets, Noncurrent - - - - -
Discontinued operations, Noncurrent - - - - -
Total Assets 1,488.09 1,540.91 1,318.57 - -
LIABILITIES
Accounts Payable and Other Accrued Liabilities, Current 49.58 - - - -
Accrued Liabilities, Current - 33.15 54.52 - -
Financial Instruments - - - - -
Shortterm Debt - - - - -
Other Liabilities, Current - 40.96 - - -
Accrued Income Taxes, Current TA - - 35.68 - -
Deferred Liability and Revenue - - - - -
Business Combination, Contingent Consideration, Liability, Current BU 50.48 44.21 22.93 - -
Contract With Customer Liability Current 18.96 21.61 7.54 - -
Total Current Liabilities 119.01 118.32 120.68 - -
Long-term debt - - - - -
Capital Lease and Other - - - - -
Long-term Debt Convertible - - - - -
Total Long-term Debt - - - - -
Financial Instruments, Insurance, Noncurrent - - - - -
Employee Benefit Plans, Noncurrent - - - - -
Deferred credits, Noncurrent - - - - -
Accrued Income Taxes, Noncurrent - - - - -
Discontinued Operation, Liabilities, Noncurrent - - - - -
Other liabilities, Noncurrent 216.76 189.31 37.62 - -
Operating Lease Liability Noncurrent 71.22 76.68 36.41 - -
Deferred Revenue And Grant Funding Noncurrent - - 60.76 - -
Deferred Income Tax Liabilities Net 30.61 33.18 37.37 - -
Total Liabilities 335.78 307.63 292.84 - -
SHAREHOLDER'S EQUITY
Common Stock Value 753.20 734.37 722.43 - -
Additional Paid In Capital Common Stock 121.05 74.12 35.36 - -
Retained Earnings / Accumulated Deficit 279.79 426.19 267.67 - -
Other Equity -1.72 -1.39 0.28 - -
Noncontrolling interests & other - - - - -
Total Stockholder's Equity 1,152.32 1,233.28 1,025.73 - -
Liabilities & Stockholder's Equity 1,488.09 1,540.91 1,318.57 - -






Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com